A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP)

NCT03013114 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Shandong University